nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—Cloperastine—Raloxifene—osteoporosis	0.431	1	CrCrCtD
Orphenadrine—CYP2B6—Raloxifene—osteoporosis	0.0737	0.19	CbGbCtD
Orphenadrine—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0712	0.183	CbGbCtD
Orphenadrine—CYP2B6—Cholecalciferol—osteoporosis	0.0569	0.146	CbGbCtD
Orphenadrine—CYP3A4—Estropipate—osteoporosis	0.0339	0.0873	CbGbCtD
Orphenadrine—CYP3A4—Calcitriol—osteoporosis	0.0339	0.0873	CbGbCtD
Orphenadrine—CYP3A4—Ergocalciferol—osteoporosis	0.0271	0.0698	CbGbCtD
Orphenadrine—CYP3A4—Raloxifene—osteoporosis	0.0227	0.0582	CbGbCtD
Orphenadrine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0219	0.0562	CbGbCtD
Orphenadrine—CYP3A4—Cholecalciferol—osteoporosis	0.0175	0.045	CbGbCtD
Orphenadrine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0161	0.0413	CbGbCtD
Orphenadrine—CYP3A4—Estradiol—osteoporosis	0.0141	0.0362	CbGbCtD
Orphenadrine—Epigastric discomfort—Calcitriol—osteoporosis	0.00553	0.0382	CcSEcCtD
Orphenadrine—Gastric irritation—Conjugated Estrogens—osteoporosis	0.00528	0.0364	CcSEcCtD
Orphenadrine—Epigastric discomfort—Conjugated Estrogens—osteoporosis	0.00389	0.0269	CcSEcCtD
Orphenadrine—Confusional state—Calcium Acetate—osteoporosis	0.00196	0.0135	CcSEcCtD
Orphenadrine—Hallucination—Etidronic acid—osteoporosis	0.00179	0.0124	CcSEcCtD
Orphenadrine—Constipation—Calcium Acetate—osteoporosis	0.00166	0.0115	CcSEcCtD
Orphenadrine—Drowsiness—Calcitriol—osteoporosis	0.00163	0.0112	CcSEcCtD
Orphenadrine—Feeling abnormal—Calcium Acetate—osteoporosis	0.0016	0.0111	CcSEcCtD
Orphenadrine—Constipation—Ergocalciferol—osteoporosis	0.00147	0.0101	CcSEcCtD
Orphenadrine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00143	0.0099	CcSEcCtD
Orphenadrine—Asthenia—Calcium Acetate—osteoporosis	0.0014	0.00964	CcSEcCtD
Orphenadrine—Pruritus—Calcium Acetate—osteoporosis	0.00138	0.00951	CcSEcCtD
Orphenadrine—Tension—Estropipate—osteoporosis	0.00133	0.00917	CcSEcCtD
Orphenadrine—Confusional state—Etidronic acid—osteoporosis	0.00129	0.00889	CcSEcCtD
Orphenadrine—Dizziness—Calcium Acetate—osteoporosis	0.00129	0.00888	CcSEcCtD
Orphenadrine—Vomiting—Calcium Acetate—osteoporosis	0.00124	0.00854	CcSEcCtD
Orphenadrine—Asthenia—Ergocalciferol—osteoporosis	0.00123	0.00851	CcSEcCtD
Orphenadrine—Palpitations—Estropipate—osteoporosis	0.0012	0.00826	CcSEcCtD
Orphenadrine—Agitation—Calcitriol—osteoporosis	0.00117	0.00807	CcSEcCtD
Orphenadrine—Nausea—Calcium Acetate—osteoporosis	0.00116	0.00798	CcSEcCtD
Orphenadrine—Palpitations—Ibandronate—osteoporosis	0.00115	0.00792	CcSEcCtD
Orphenadrine—Anaphylactic shock—Estropipate—osteoporosis	0.0011	0.00763	CcSEcCtD
Orphenadrine—Constipation—Etidronic acid—osteoporosis	0.00109	0.00754	CcSEcCtD
Orphenadrine—Skin disorder—Estropipate—osteoporosis	0.00107	0.00741	CcSEcCtD
Orphenadrine—Anaphylactic shock—Ibandronate—osteoporosis	0.00106	0.00732	CcSEcCtD
Orphenadrine—Feeling abnormal—Etidronic acid—osteoporosis	0.00105	0.00727	CcSEcCtD
Orphenadrine—Skin disorder—Raloxifene—osteoporosis	0.00104	0.00718	CcSEcCtD
Orphenadrine—Anaphylactic shock—Calcitriol—osteoporosis	0.00104	0.00716	CcSEcCtD
Orphenadrine—Skin disorder—Ibandronate—osteoporosis	0.00103	0.00711	CcSEcCtD
Orphenadrine—Nausea—Ergocalciferol—osteoporosis	0.00102	0.00705	CcSEcCtD
Orphenadrine—Urticaria—Etidronic acid—osteoporosis	0.00101	0.00701	CcSEcCtD
Orphenadrine—Skin disorder—Calcitriol—osteoporosis	0.00101	0.00696	CcSEcCtD
Orphenadrine—Tension—Pamidronate—osteoporosis	0.000998	0.00689	CcSEcCtD
Orphenadrine—Somnolence—Estropipate—osteoporosis	0.000982	0.00678	CcSEcCtD
Orphenadrine—Constipation—Estropipate—osteoporosis	0.000945	0.00652	CcSEcCtD
Orphenadrine—Hypersensitivity—Etidronic acid—osteoporosis	0.000941	0.0065	CcSEcCtD
Orphenadrine—Agitation—Pamidronate—osteoporosis	0.000934	0.00645	CcSEcCtD
Orphenadrine—Constipation—Alendronate—osteoporosis	0.00093	0.00643	CcSEcCtD
Orphenadrine—Somnolence—Calcitriol—osteoporosis	0.000922	0.00637	CcSEcCtD
Orphenadrine—Constipation—Ibandronate—osteoporosis	0.000906	0.00626	CcSEcCtD
Orphenadrine—Pruritus—Etidronic acid—osteoporosis	0.000903	0.00624	CcSEcCtD
Orphenadrine—Feeling abnormal—Alendronate—osteoporosis	0.000896	0.00619	CcSEcCtD
Orphenadrine—Constipation—Calcitriol—osteoporosis	0.000887	0.00613	CcSEcCtD
Orphenadrine—Tension—Conjugated Estrogens—osteoporosis	0.000878	0.00606	CcSEcCtD
Orphenadrine—Urticaria—Estropipate—osteoporosis	0.000877	0.00606	CcSEcCtD
Orphenadrine—Vision blurred—Zoledronate—osteoporosis	0.000875	0.00605	CcSEcCtD
Orphenadrine—Feeling abnormal—Ibandronate—osteoporosis	0.000873	0.00603	CcSEcCtD
Orphenadrine—Tremor—Zoledronate—osteoporosis	0.00087	0.00601	CcSEcCtD
Orphenadrine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00087	0.00601	CcSEcCtD
Orphenadrine—Urticaria—Alendronate—osteoporosis	0.000864	0.00597	CcSEcCtD
Orphenadrine—Agitation—Zoledronate—osteoporosis	0.000853	0.0059	CcSEcCtD
Orphenadrine—Skin disorder—Risedronate—osteoporosis	0.000848	0.00586	CcSEcCtD
Orphenadrine—Vision blurred—Conjugated Estrogens—osteoporosis	0.000843	0.00582	CcSEcCtD
Orphenadrine—Urticaria—Ibandronate—osteoporosis	0.000841	0.00581	CcSEcCtD
Orphenadrine—Confusional state—Pamidronate—osteoporosis	0.000837	0.00578	CcSEcCtD
Orphenadrine—Anaphylactic shock—Pamidronate—osteoporosis	0.00083	0.00573	CcSEcCtD
Orphenadrine—Urticaria—Calcitriol—osteoporosis	0.000824	0.00569	CcSEcCtD
Orphenadrine—Palpitations—Zoledronate—osteoporosis	0.000821	0.00567	CcSEcCtD
Orphenadrine—Hypersensitivity—Estropipate—osteoporosis	0.000814	0.00562	CcSEcCtD
Orphenadrine—Vomiting—Etidronic acid—osteoporosis	0.000812	0.00561	CcSEcCtD
Orphenadrine—Tachycardia—Pamidronate—osteoporosis	0.00081	0.00559	CcSEcCtD
Orphenadrine—Hypersensitivity—Alendronate—osteoporosis	0.000802	0.00554	CcSEcCtD
Orphenadrine—Headache—Etidronic acid—osteoporosis	0.0008	0.00553	CcSEcCtD
Orphenadrine—Asthenia—Estropipate—osteoporosis	0.000792	0.00547	CcSEcCtD
Orphenadrine—Palpitations—Conjugated Estrogens—osteoporosis	0.00079	0.00546	CcSEcCtD
Orphenadrine—Pruritus—Estropipate—osteoporosis	0.000781	0.0054	CcSEcCtD
Orphenadrine—Asthenia—Alendronate—osteoporosis	0.000781	0.00539	CcSEcCtD
Orphenadrine—Hypersensitivity—Ibandronate—osteoporosis	0.00078	0.00539	CcSEcCtD
Orphenadrine—Pruritus—Alendronate—osteoporosis	0.00077	0.00532	CcSEcCtD
Orphenadrine—Constipation—Ethinyl Estradiol—osteoporosis	0.000766	0.00529	CcSEcCtD
Orphenadrine—Confusional state—Zoledronate—osteoporosis	0.000764	0.00528	CcSEcCtD
Orphenadrine—Hypersensitivity—Calcitriol—osteoporosis	0.000764	0.00528	CcSEcCtD
Orphenadrine—Asthenia—Ibandronate—osteoporosis	0.00076	0.00525	CcSEcCtD
Orphenadrine—Nausea—Etidronic acid—osteoporosis	0.000758	0.00524	CcSEcCtD
Orphenadrine—Anaphylactic shock—Zoledronate—osteoporosis	0.000758	0.00524	CcSEcCtD
Orphenadrine—Pruritus—Ibandronate—osteoporosis	0.000749	0.00518	CcSEcCtD
Orphenadrine—Constipation—Risedronate—osteoporosis	0.000746	0.00516	CcSEcCtD
Orphenadrine—Asthenia—Calcitriol—osteoporosis	0.000744	0.00514	CcSEcCtD
Orphenadrine—Tachycardia—Zoledronate—osteoporosis	0.00074	0.00511	CcSEcCtD
Orphenadrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000738	0.0051	CcSEcCtD
Orphenadrine—Somnolence—Pamidronate—osteoporosis	0.000738	0.0051	CcSEcCtD
Orphenadrine—Skin disorder—Zoledronate—osteoporosis	0.000736	0.00509	CcSEcCtD
Orphenadrine—Pruritus—Calcitriol—osteoporosis	0.000734	0.00507	CcSEcCtD
Orphenadrine—Dizziness—Estropipate—osteoporosis	0.00073	0.00505	CcSEcCtD
Orphenadrine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00073	0.00504	CcSEcCtD
Orphenadrine—Dizziness—Alendronate—osteoporosis	0.000719	0.00497	CcSEcCtD
Orphenadrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000712	0.00492	CcSEcCtD
Orphenadrine—Urticaria—Ethinyl Estradiol—osteoporosis	0.000711	0.00491	CcSEcCtD
Orphenadrine—Constipation—Pamidronate—osteoporosis	0.00071	0.0049	CcSEcCtD
Orphenadrine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000709	0.0049	CcSEcCtD
Orphenadrine—Dizziness—Raloxifene—osteoporosis	0.000708	0.00489	CcSEcCtD
Orphenadrine—Tension—Estradiol—osteoporosis	0.000702	0.00485	CcSEcCtD
Orphenadrine—Vomiting—Estropipate—osteoporosis	0.000702	0.00485	CcSEcCtD
Orphenadrine—Dizziness—Ibandronate—osteoporosis	0.0007	0.00484	CcSEcCtD
Orphenadrine—Urticaria—Risedronate—osteoporosis	0.000693	0.00479	CcSEcCtD
Orphenadrine—Headache—Estropipate—osteoporosis	0.000692	0.00478	CcSEcCtD
Orphenadrine—Vomiting—Alendronate—osteoporosis	0.000692	0.00478	CcSEcCtD
Orphenadrine—Feeling abnormal—Pamidronate—osteoporosis	0.000684	0.00472	CcSEcCtD
Orphenadrine—Headache—Alendronate—osteoporosis	0.000682	0.00471	CcSEcCtD
Orphenadrine—Vomiting—Raloxifene—osteoporosis	0.00068	0.0047	CcSEcCtD
Orphenadrine—Somnolence—Zoledronate—osteoporosis	0.000674	0.00465	CcSEcCtD
Orphenadrine—Vomiting—Ibandronate—osteoporosis	0.000673	0.00465	CcSEcCtD
Orphenadrine—Tremor—Estradiol—osteoporosis	0.000671	0.00463	CcSEcCtD
Orphenadrine—Headache—Raloxifene—osteoporosis	0.00067	0.00463	CcSEcCtD
Orphenadrine—Headache—Ibandronate—osteoporosis	0.000664	0.00458	CcSEcCtD
Orphenadrine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00066	0.00456	CcSEcCtD
Orphenadrine—Vomiting—Calcitriol—osteoporosis	0.000659	0.00455	CcSEcCtD
Orphenadrine—Agitation—Estradiol—osteoporosis	0.000658	0.00454	CcSEcCtD
Orphenadrine—Nausea—Estropipate—osteoporosis	0.000656	0.00453	CcSEcCtD
Orphenadrine—Headache—Calcitriol—osteoporosis	0.00065	0.00449	CcSEcCtD
Orphenadrine—Somnolence—Conjugated Estrogens—osteoporosis	0.000649	0.00448	CcSEcCtD
Orphenadrine—Constipation—Zoledronate—osteoporosis	0.000648	0.00448	CcSEcCtD
Orphenadrine—Nausea—Alendronate—osteoporosis	0.000646	0.00446	CcSEcCtD
Orphenadrine—Hypersensitivity—Risedronate—osteoporosis	0.000643	0.00444	CcSEcCtD
Orphenadrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000642	0.00444	CcSEcCtD
Orphenadrine—Nausea—Raloxifene—osteoporosis	0.000636	0.00439	CcSEcCtD
Orphenadrine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000633	0.00438	CcSEcCtD
Orphenadrine—Palpitations—Estradiol—osteoporosis	0.000632	0.00437	CcSEcCtD
Orphenadrine—Nausea—Ibandronate—osteoporosis	0.000629	0.00435	CcSEcCtD
Orphenadrine—Asthenia—Risedronate—osteoporosis	0.000626	0.00433	CcSEcCtD
Orphenadrine—Feeling abnormal—Zoledronate—osteoporosis	0.000625	0.00431	CcSEcCtD
Orphenadrine—Constipation—Conjugated Estrogens—osteoporosis	0.000624	0.00431	CcSEcCtD
Orphenadrine—Toremifene—ESR1—osteoporosis	0.000623	0.274	CrCbGaD
Orphenadrine—Pruritus—Risedronate—osteoporosis	0.000618	0.00427	CcSEcCtD
Orphenadrine—Nausea—Calcitriol—osteoporosis	0.000616	0.00425	CcSEcCtD
Orphenadrine—Hypersensitivity—Pamidronate—osteoporosis	0.000611	0.00422	CcSEcCtD
Orphenadrine—Urticaria—Zoledronate—osteoporosis	0.000602	0.00416	CcSEcCtD
Orphenadrine—Asthenia—Pamidronate—osteoporosis	0.000595	0.00411	CcSEcCtD
Orphenadrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000592	0.00409	CcSEcCtD
Orphenadrine—Confusional state—Estradiol—osteoporosis	0.000589	0.00407	CcSEcCtD
Orphenadrine—Pruritus—Pamidronate—osteoporosis	0.000587	0.00406	CcSEcCtD
Orphenadrine—Anaphylactic shock—Estradiol—osteoporosis	0.000584	0.00404	CcSEcCtD
Orphenadrine—Urticaria—Conjugated Estrogens—osteoporosis	0.00058	0.00401	CcSEcCtD
Orphenadrine—Dizziness—Risedronate—osteoporosis	0.000577	0.00399	CcSEcCtD
Orphenadrine—Tachycardia—Estradiol—osteoporosis	0.00057	0.00394	CcSEcCtD
Orphenadrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000569	0.00393	CcSEcCtD
Orphenadrine—Skin disorder—Estradiol—osteoporosis	0.000567	0.00392	CcSEcCtD
Orphenadrine—Headache—Ethinyl Estradiol—osteoporosis	0.000561	0.00387	CcSEcCtD
Orphenadrine—Hypersensitivity—Zoledronate—osteoporosis	0.000558	0.00386	CcSEcCtD
Orphenadrine—Vomiting—Risedronate—osteoporosis	0.000555	0.00383	CcSEcCtD
Orphenadrine—Dizziness—Pamidronate—osteoporosis	0.000549	0.00379	CcSEcCtD
Orphenadrine—Headache—Risedronate—osteoporosis	0.000547	0.00378	CcSEcCtD
Orphenadrine—Asthenia—Zoledronate—osteoporosis	0.000544	0.00376	CcSEcCtD
Orphenadrine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000538	0.00371	CcSEcCtD
Orphenadrine—Pruritus—Zoledronate—osteoporosis	0.000536	0.0037	CcSEcCtD
Orphenadrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000532	0.00367	CcSEcCtD
Orphenadrine—Vomiting—Pamidronate—osteoporosis	0.000528	0.00364	CcSEcCtD
Orphenadrine—Asthenia—Conjugated Estrogens—osteoporosis	0.000524	0.00362	CcSEcCtD
Orphenadrine—Headache—Pamidronate—osteoporosis	0.00052	0.00359	CcSEcCtD
Orphenadrine—Somnolence—Estradiol—osteoporosis	0.000519	0.00359	CcSEcCtD
Orphenadrine—Nausea—Risedronate—osteoporosis	0.000518	0.00358	CcSEcCtD
Orphenadrine—Pruritus—Conjugated Estrogens—osteoporosis	0.000516	0.00357	CcSEcCtD
Orphenadrine—Dizziness—Zoledronate—osteoporosis	0.000501	0.00346	CcSEcCtD
Orphenadrine—Constipation—Estradiol—osteoporosis	0.0005	0.00345	CcSEcCtD
Orphenadrine—Nausea—Pamidronate—osteoporosis	0.000493	0.0034	CcSEcCtD
Orphenadrine—Dizziness—Conjugated Estrogens—osteoporosis	0.000483	0.00333	CcSEcCtD
Orphenadrine—Vomiting—Zoledronate—osteoporosis	0.000482	0.00333	CcSEcCtD
Orphenadrine—Feeling abnormal—Estradiol—osteoporosis	0.000481	0.00333	CcSEcCtD
Orphenadrine—Headache—Zoledronate—osteoporosis	0.000475	0.00328	CcSEcCtD
Orphenadrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000464	0.00321	CcSEcCtD
Orphenadrine—Urticaria—Estradiol—osteoporosis	0.000464	0.00321	CcSEcCtD
Orphenadrine—Levomethadyl Acetate—CYP19A1—osteoporosis	0.000457	0.201	CrCbGaD
Orphenadrine—Headache—Conjugated Estrogens—osteoporosis	0.000457	0.00316	CcSEcCtD
Orphenadrine—Nausea—Zoledronate—osteoporosis	0.00045	0.00311	CcSEcCtD
Orphenadrine—Nausea—Conjugated Estrogens—osteoporosis	0.000434	0.00299	CcSEcCtD
Orphenadrine—Hypersensitivity—Estradiol—osteoporosis	0.00043	0.00297	CcSEcCtD
Orphenadrine—Asthenia—Estradiol—osteoporosis	0.000419	0.0029	CcSEcCtD
Orphenadrine—Pruritus—Estradiol—osteoporosis	0.000413	0.00285	CcSEcCtD
Orphenadrine—Tamoxifen—ESR2—osteoporosis	0.000404	0.178	CrCbGaD
Orphenadrine—Dizziness—Estradiol—osteoporosis	0.000386	0.00267	CcSEcCtD
Orphenadrine—Vomiting—Estradiol—osteoporosis	0.000371	0.00257	CcSEcCtD
Orphenadrine—Headache—Estradiol—osteoporosis	0.000366	0.00253	CcSEcCtD
Orphenadrine—Nausea—Estradiol—osteoporosis	0.000347	0.0024	CcSEcCtD
Orphenadrine—Tamoxifen—CYP19A1—osteoporosis	0.00027	0.119	CrCbGaD
Orphenadrine—Methadone—CYP19A1—osteoporosis	0.000268	0.118	CrCbGaD
Orphenadrine—Tamoxifen—ESR1—osteoporosis	0.000249	0.11	CrCbGaD
Orphenadrine—SCN9A—Developmental Biology—IL6R—osteoporosis	5.54e-05	0.00169	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—PTH—osteoporosis	5.33e-05	0.00162	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	5.31e-05	0.00162	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.25e-05	0.0016	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—PTH—osteoporosis	5.25e-05	0.0016	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	5.24e-05	0.00159	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CALCR—osteoporosis	5.21e-05	0.00159	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTH1R—osteoporosis	5.21e-05	0.00159	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CNR2—osteoporosis	5.2e-05	0.00158	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CALCR—osteoporosis	5.13e-05	0.00156	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTH1R—osteoporosis	5.13e-05	0.00156	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CNR2—osteoporosis	5.11e-05	0.00156	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—IL6R—osteoporosis	5.09e-05	0.00155	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6R—osteoporosis	4.91e-05	0.00149	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6R—osteoporosis	4.91e-05	0.00149	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—WNT1—osteoporosis	4.89e-05	0.00149	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6R—osteoporosis	4.84e-05	0.00147	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—WNT1—osteoporosis	4.81e-05	0.00146	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—LEP—osteoporosis	4.79e-05	0.00146	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—TNF—osteoporosis	4.79e-05	0.00146	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—TNF—osteoporosis	4.65e-05	0.00141	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—MGLL—osteoporosis	4.56e-05	0.00139	CbGpPWpGaD
Orphenadrine—GRIN1—SIDS Susceptibility Pathways—IL6—osteoporosis	4.5e-05	0.00137	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—ADCY5—osteoporosis	4.5e-05	0.00137	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—MGLL—osteoporosis	4.48e-05	0.00136	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6R—osteoporosis	4.48e-05	0.00136	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—PTHLH—osteoporosis	4.42e-05	0.00134	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—PTHLH—osteoporosis	4.35e-05	0.00132	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MGLL—osteoporosis	4.14e-05	0.00126	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—LEP—osteoporosis	4.12e-05	0.00125	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MGLL—osteoporosis	4.07e-05	0.00124	CbGpPWpGaD
Orphenadrine—SLC6A2—NRF2 pathway—TGFB1—osteoporosis	4.06e-05	0.00124	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6R—osteoporosis	4.02e-05	0.00122	CbGpPWpGaD
Orphenadrine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.89e-05	0.00118	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—CALCA—osteoporosis	3.89e-05	0.00118	CbGpPWpGaD
Orphenadrine—SCN5A—SIDS Susceptibility Pathways—IL6—osteoporosis	3.87e-05	0.00118	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—CALCA—osteoporosis	3.83e-05	0.00117	CbGpPWpGaD
Orphenadrine—KCNH2—SIDS Susceptibility Pathways—IL6—osteoporosis	3.75e-05	0.00114	CbGpPWpGaD
Orphenadrine—CYP2B6—Biological oxidations—POMC—osteoporosis	3.69e-05	0.00112	CbGpPWpGaD
Orphenadrine—CYP2E1—Biological oxidations—POMC—osteoporosis	3.61e-05	0.0011	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	3.52e-05	0.00107	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PKM—osteoporosis	3.48e-05	0.00106	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—FDPS—osteoporosis	3.48e-05	0.00106	CbGpPWpGaD
Orphenadrine—SCN9A—Axon guidance—IL6—osteoporosis	3.46e-05	0.00105	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6R—osteoporosis	3.45e-05	0.00105	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PKM—osteoporosis	3.41e-05	0.00104	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—FDPS—osteoporosis	3.41e-05	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	3.41e-05	0.00104	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SOST—osteoporosis	3.4e-05	0.00104	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SOST—osteoporosis	3.35e-05	0.00102	CbGpPWpGaD
Orphenadrine—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	3.31e-05	0.00101	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPD2—osteoporosis	3.3e-05	0.001	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PGLS—osteoporosis	3.3e-05	0.001	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TGFB1—osteoporosis	3.28e-05	0.000997	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PGLS—osteoporosis	3.23e-05	0.000983	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPD2—osteoporosis	3.23e-05	0.000983	CbGpPWpGaD
Orphenadrine—SCN4A—Axon guidance—IL6—osteoporosis	3.18e-05	0.000968	CbGpPWpGaD
Orphenadrine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.15e-05	0.00096	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTH1R—osteoporosis	3.08e-05	0.000937	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CALCR—osteoporosis	3.08e-05	0.000937	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.07e-05	0.000933	CbGpPWpGaD
Orphenadrine—SCN10A—Axon guidance—IL6—osteoporosis	3.07e-05	0.000933	CbGpPWpGaD
Orphenadrine—SCN1A—Axon guidance—IL6—osteoporosis	3.07e-05	0.000933	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—TNF—osteoporosis	3.06e-05	0.000931	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTH1R—osteoporosis	3.03e-05	0.000922	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CALCR—osteoporosis	3.03e-05	0.000922	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ATIC—osteoporosis	3.02e-05	0.000918	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PNP—osteoporosis	3.02e-05	0.000918	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PTH—osteoporosis	3.01e-05	0.000917	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TGFB1—osteoporosis	3.01e-05	0.000916	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PTH—osteoporosis	2.96e-05	0.000903	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PNP—osteoporosis	2.95e-05	0.000899	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ATIC—osteoporosis	2.95e-05	0.000899	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CNR2—osteoporosis	2.94e-05	0.000894	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TGFB1—osteoporosis	2.9e-05	0.000884	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TGFB1—osteoporosis	2.9e-05	0.000884	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	2.89e-05	0.00088	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—TNF—osteoporosis	2.81e-05	0.000856	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.79e-05	0.000849	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.75e-05	0.000837	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTH—osteoporosis	2.74e-05	0.000833	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—TNF—osteoporosis	2.71e-05	0.000825	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—TNF—osteoporosis	2.71e-05	0.000825	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTH—osteoporosis	2.69e-05	0.00082	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.67e-05	0.000814	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CNR2—osteoporosis	2.67e-05	0.000812	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.63e-05	0.0008	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CNR2—osteoporosis	2.62e-05	0.000799	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—OXCT1—osteoporosis	2.56e-05	0.000781	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CA2—osteoporosis	2.56e-05	0.000781	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—OXCT1—osteoporosis	2.51e-05	0.000765	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CA2—osteoporosis	2.51e-05	0.000765	CbGpPWpGaD
Orphenadrine—GRIN1—Axon guidance—IL6—osteoporosis	2.51e-05	0.000763	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—WNT1—osteoporosis	2.51e-05	0.000763	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MGLL—osteoporosis	2.5e-05	0.000761	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PTHLH—osteoporosis	2.5e-05	0.00076	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	2.47e-05	0.000752	CbGpPWpGaD
Orphenadrine—SCN9A—Developmental Biology—IL6—osteoporosis	2.47e-05	0.000751	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—WNT1—osteoporosis	2.47e-05	0.000751	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	2.46e-05	0.000748	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MGLL—osteoporosis	2.45e-05	0.000745	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MGLL—osteoporosis	2.44e-05	0.000744	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MGLL—osteoporosis	2.41e-05	0.000732	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LRP5—osteoporosis	2.39e-05	0.000726	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TGFB1—osteoporosis	2.37e-05	0.000723	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LRP5—osteoporosis	2.35e-05	0.000715	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LRP6—osteoporosis	2.28e-05	0.000695	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—IL6—osteoporosis	2.27e-05	0.000691	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PTHLH—osteoporosis	2.27e-05	0.00069	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LRP6—osteoporosis	2.25e-05	0.000684	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	2.23e-05	0.000679	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—TNF—osteoporosis	2.22e-05	0.000675	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—CALCA—osteoporosis	2.2e-05	0.000669	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—IL6—osteoporosis	2.19e-05	0.000666	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—IL6—osteoporosis	2.19e-05	0.000666	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	2.16e-05	0.000658	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—IL6—osteoporosis	2.16e-05	0.000656	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—IDH2—osteoporosis	2.12e-05	0.000647	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—IDH2—osteoporosis	2.08e-05	0.000634	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TGFB1—osteoporosis	2.04e-05	0.000621	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—POMC—osteoporosis	2.04e-05	0.00062	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—POMC—osteoporosis	2e-05	0.00061	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP27A1—osteoporosis	2e-05	0.000608	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—CALCA—osteoporosis	2e-05	0.000608	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	1.99e-05	0.000607	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—CALCA—osteoporosis	1.96e-05	0.000598	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP27A1—osteoporosis	1.96e-05	0.000596	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ACP5—osteoporosis	1.94e-05	0.000592	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TLN1—osteoporosis	1.93e-05	0.000587	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—TNF—osteoporosis	1.91e-05	0.00058	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ACP5—osteoporosis	1.9e-05	0.000579	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TLN1—osteoporosis	1.9e-05	0.000577	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—TPI1—osteoporosis	1.81e-05	0.00055	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—IL6—osteoporosis	1.79e-05	0.000545	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—TPI1—osteoporosis	1.77e-05	0.000539	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—P4HB—osteoporosis	1.7e-05	0.000517	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—osteoporosis	1.68e-05	0.00051	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GAPDH—osteoporosis	1.67e-05	0.000508	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—P4HB—osteoporosis	1.66e-05	0.000506	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—P4HB—osteoporosis	1.66e-05	0.000506	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—P4HB—osteoporosis	1.64e-05	0.000498	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GAPDH—osteoporosis	1.63e-05	0.000497	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—RAP1A—osteoporosis	1.62e-05	0.000494	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTH—osteoporosis	1.62e-05	0.000492	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—RAP1A—osteoporosis	1.59e-05	0.000484	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTH—osteoporosis	1.59e-05	0.000484	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAP1A—osteoporosis	1.59e-05	0.000484	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PKM—osteoporosis	1.58e-05	0.000481	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FDPS—osteoporosis	1.58e-05	0.000481	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CNR2—osteoporosis	1.58e-05	0.00048	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.57e-05	0.000477	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ADCY5—osteoporosis	1.56e-05	0.000476	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAP1A—osteoporosis	1.56e-05	0.000476	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CNR2—osteoporosis	1.55e-05	0.000472	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—NFATC1—osteoporosis	1.55e-05	0.000472	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	1.54e-05	0.000468	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—IL6—osteoporosis	1.54e-05	0.000468	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—DKK1—osteoporosis	1.54e-05	0.000468	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—NFATC1—osteoporosis	1.52e-05	0.000464	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—DKK1—osteoporosis	1.51e-05	0.000461	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPD2—osteoporosis	1.5e-05	0.000456	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PGLS—osteoporosis	1.5e-05	0.000456	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—WNT1—osteoporosis	1.48e-05	0.000451	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—WNT1—osteoporosis	1.46e-05	0.000444	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGA—osteoporosis	1.44e-05	0.000439	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ADCY5—osteoporosis	1.42e-05	0.000432	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGA—osteoporosis	1.42e-05	0.000432	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	1.4e-05	0.000425	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ATIC—osteoporosis	1.37e-05	0.000417	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PNP—osteoporosis	1.37e-05	0.000417	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTHLH—osteoporosis	1.34e-05	0.000408	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BMP2—osteoporosis	1.34e-05	0.000408	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTHLH—osteoporosis	1.32e-05	0.000401	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BMP2—osteoporosis	1.32e-05	0.000401	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ENO1—osteoporosis	1.31e-05	0.0004	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FGB—osteoporosis	1.31e-05	0.000399	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000394	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000394	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FGB—osteoporosis	1.29e-05	0.000393	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ENO1—osteoporosis	1.29e-05	0.000391	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PSMA2—osteoporosis	1.27e-05	0.000386	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PSMA5—osteoporosis	1.27e-05	0.000386	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSMA2—osteoporosis	1.27e-05	0.000385	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSMA5—osteoporosis	1.27e-05	0.000385	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSMA2—osteoporosis	1.25e-05	0.000379	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSMA5—osteoporosis	1.25e-05	0.000379	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CALCA—osteoporosis	1.18e-05	0.000359	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA2—osteoporosis	1.17e-05	0.000355	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.17e-05	0.000355	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CALCA—osteoporosis	1.16e-05	0.000353	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—osteoporosis	1.15e-05	0.00035	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MGLL—osteoporosis	1.14e-05	0.000346	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.13e-05	0.000344	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KL—osteoporosis	1.07e-05	0.000326	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KL—osteoporosis	1.05e-05	0.000321	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.05e-05	0.000319	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—osteoporosis	1.04e-05	0.000318	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP19A1—osteoporosis	1.03e-05	0.000313	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.03e-05	0.000313	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6R—osteoporosis	1.02e-05	0.00031	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1e-05	0.000305	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—IDH2—osteoporosis	9.66e-06	0.000294	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP27A1—osteoporosis	9.08e-06	0.000276	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACP5—osteoporosis	8.83e-06	0.000269	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ADCY5—osteoporosis	8.57e-06	0.000261	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPX1—osteoporosis	8.55e-06	0.00026	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ADCY5—osteoporosis	8.4e-06	0.000256	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ADCY5—osteoporosis	8.39e-06	0.000255	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPX1—osteoporosis	8.37e-06	0.000255	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ADCY5—osteoporosis	8.25e-06	0.000251	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—TPI1—osteoporosis	8.21e-06	0.00025	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SPP1—osteoporosis	8.11e-06	0.000247	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SPP1—osteoporosis	7.98e-06	0.000243	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—MTHFR—osteoporosis	7.89e-06	0.00024	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—MTHFR—osteoporosis	7.72e-06	0.000235	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—P4HB—osteoporosis	7.72e-06	0.000235	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.58e-06	0.000231	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—RAP1A—osteoporosis	7.38e-06	0.000225	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IRS2—osteoporosis	7.34e-06	0.000223	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IRS2—osteoporosis	7.22e-06	0.00022	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—LEP—osteoporosis	7.18e-06	0.000219	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—LEP—osteoporosis	7.07e-06	0.000215	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ESR1—osteoporosis	6.86e-06	0.000209	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ESR1—osteoporosis	6.75e-06	0.000205	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IRS1—osteoporosis	6.41e-06	0.000195	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—osteoporosis	6.31e-06	0.000192	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IRS1—osteoporosis	6.3e-06	0.000192	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—osteoporosis	6.18e-06	0.000188	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—osteoporosis	6.17e-06	0.000188	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—osteoporosis	6.07e-06	0.000185	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6R—osteoporosis	6.02e-06	0.000183	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ENO1—osteoporosis	5.97e-06	0.000182	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1—osteoporosis	5.93e-06	0.000181	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6R—osteoporosis	5.92e-06	0.00018	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.88e-06	0.000179	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.88e-06	0.000179	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1—osteoporosis	5.84e-06	0.000178	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.77e-06	0.000145	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL6—osteoporosis	4.54e-06	0.000138	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL6—osteoporosis	4.47e-06	0.000136	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.9e-06	0.000119	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPX1—osteoporosis	3.88e-06	0.000118	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.58e-06	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—osteoporosis	3.57e-06	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TGFB1—osteoporosis	3.56e-06	0.000108	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—osteoporosis	3.51e-06	0.000107	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TGFB1—osteoporosis	3.5e-06	0.000107	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—osteoporosis	2.87e-06	8.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL6—osteoporosis	2.68e-06	8.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL6—osteoporosis	2.64e-06	8.03e-05	CbGpPWpGaD
